PHIRE

Photoacoustic imaging and artificial intelligence-based theranostic approach for cancer

In the intricate realm of healthcare, the challenge of combating chemoresistant neoplastic lesions under 1 mm in size has persistently confounded medical experts. By evading conventional diagnostic and therapeutic methods, these lesions pose a serious threat to patient well-being. In this context, the EIC-funded PHIRE project aims to reshape this landscape, offering a beacon of hope in the form of a revolutionary high-resolution theranostic medical device that integrates an add-on module for deep organ imaging, guided by AI-driven gold nanorod therapy. Crucially, urine-stable nanorods ensure safety. Overall, PHIRE’s potential to reduce relapses and patient burden marks a paradigm shift. Beyond medicine, PHIRE resonates in imaging, nanotechnology, and software markets.